Recipharm Partners for Early-Stage Development

From DCAT Value Chain Insights (VCI)

By Supplier News posted 09-19-2017 15:32


Recipharm, a Swedish contract development and manufacturing organization, and Clinical Trial Consultants (CTC), a contract research organization, have partnered to launch a new service, Pathway to Clinic, which is designed to deliver a streamlined pathway to first-in-human milestones.

Recipharm Pathway to Clinic takes projects from early-phase formulation development through to clinical trial implementation. Recipharm performs formulation development, GMP clinical supply manufacture, and bioanalysis from its development sites in Solna and Uppsala, Sweden. CTC supports customers with hospital-based early-phase (0/I/IIa) clinical trials, including patient recruitment, trial design, implementation and data evaluation. Recipharm’s capabilities will be integrated with CTC’s clinical trial capability and managing of Phase I trials at Akademiska University Hospital in Uppsala.

Source: Recipharm


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription